Explore how the 30-month stay under the Hatch-Waxman Act delays generic drug approval through patent litigation. Learn about Paragraph IV certifications, economic impacts, and upcoming reforms.
Explore how the 30-month stay under the Hatch-Waxman Act delays generic drug approval through patent litigation. Learn about Paragraph IV certifications, economic impacts, and upcoming reforms.
Health Policy